Sustainable development

Our sustainability work includes the environment, occupational health and safety, social responsibility and finances.​Sustainable business is a given for us and an integral part of our strategy, and is part of our business development.​We always take responsibility for the entire flow and for the next generation.​

Sustainability work reported according to GRI

Every year, we report the outcome of our work on sustainable development. For the eighth year running, we are reporting the sustainability work according to Global Reporting Initiative’s (GRI) guidelines and, as from our financial year 2018, according to GRI SRS (Sustainability Reporting Standards), a global standard for sustainability reporting level Core.

The sustainability report complies with the guidelines for external reporting for companies with state ownership, and it is audited by a third party.

Read more in our Annual and Sustainability Report (in Swedish) Opens in new window.


Extemporeläkemedel och lagerberedningar

Beställ online via EbEx


Telefon: 010-447 97 00


Ordinarie öppettider:
Helgfria vardagar 08:00-17:00



Reservrutinen används endast för akuta medicinskt viktiga beställningar av extemporeläkemedel under tiden EbEx ordersystem inte kan nås. För att kunna använda dig av rutinen så krävs det att du redan är befintlig kund hos APL och har ett kundnummer.

Beställningar görs på för ändamålet avsedd blankett och får inte innehålla några patientuppgifter.

Beställningen skickas via e-post till



Visiting adress:

Prismavägen 2, Kungens Kurva

+46 10 447 96 00

Other contact information

About APL

Apotek Produktion & Laboratorier (APL) is one of Europe’s leading companies manufacturing extemporaneous drugs and stock preparations. We have a social mission from the Swedish government, but also work together with other pharmaceutical companies to create the greatest possible patient benefit. Our vision is that we will make a difference for patients with special needs. We are also an established contract manufacturer within Life Science in Scandinavia, where we deliver services within development and analysis. With more than 500 employees and five manufacturing units in Malmö, Gothenburg, Stockholm and Umeå, we develop drugs that improve and save lives.

Read more